These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 7678072)
1. Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein. Arceci RJ; Stieglitz K; Bras J; Schinkel A; Baas F; Croop J Cancer Res; 1993 Jan; 53(2):310-7. PubMed ID: 7678072 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. Schinkel AH; Roelofs EM; Borst P Cancer Res; 1991 May; 51(10):2628-35. PubMed ID: 1673638 [TBL] [Abstract][Full Text] [Related]
3. High-affinity monoclonal antibodies against P-glycoprotein. Shi T; Wrin J; Reeder J; Liu D; Ring DB Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):44-51. PubMed ID: 7541735 [TBL] [Abstract][Full Text] [Related]
4. Characterization of monoclonal antibodies recognizing a Mr 180,000 P-glycoprotein: differential expression of the Mr 180,000 and Mr 170,000 P-glycoproteins in multidrug-resistant human tumor cells. Meyers MB; Rittmann-Grauer L; O'Brien JP; Safa AR Cancer Res; 1989 Jun; 49(12):3209-14. PubMed ID: 2566379 [TBL] [Abstract][Full Text] [Related]
5. Mouse-human chimeric antibody against the multidrug transporter P-glycoprotein. Hamada H; Miura K; Ariyoshi K; Heike Y; Sato S; Kameyama K; Kurosawa Y; Tsuruo T Cancer Res; 1990 Jun; 50(11):3167-71. PubMed ID: 1970754 [TBL] [Abstract][Full Text] [Related]
6. MDR1 gene-specific monoclonal antibody C494 cross-reacts with pyruvate carboxylase. Rao VV; Anthony DC; Piwnica-Worms D Cancer Res; 1994 Mar; 54(6):1536-41. PubMed ID: 7511043 [TBL] [Abstract][Full Text] [Related]
7. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution. Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675 [TBL] [Abstract][Full Text] [Related]
8. Expression of P-glycoprotein in normal muscle cells and myogenic tumors. Garberoglio C; Dudas M; Casper ES; Bertino J; Cordon-Cardo C Arch Pathol Lab Med; 1992 Oct; 116(10):1055-61. PubMed ID: 1384456 [TBL] [Abstract][Full Text] [Related]
9. Antigens associated with multidrug resistance in H69AR, a small cell lung cancer cell line. Mirski SE; Cole SP Cancer Res; 1989 Oct; 49(20):5719-24. PubMed ID: 2571409 [TBL] [Abstract][Full Text] [Related]
10. Reversal of etoposide resistance in non-P-glycoprotein expressing multidrug resistant tumor cell lines by novobiocin. Rappa G; Lorico A; Sartorelli AC Cancer Res; 1993 Nov; 53(22):5487-93. PubMed ID: 8106148 [TBL] [Abstract][Full Text] [Related]
11. Detection of soluble P-glycoprotein in culture media and extracellular fluids. Chu TM; Lin TH; Kawinski E Biochem Biophys Res Commun; 1994 Aug; 203(1):506-12. PubMed ID: 7915520 [TBL] [Abstract][Full Text] [Related]
12. Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi. Rao VV; Chiu ML; Kronauge JF; Piwnica-Worms D J Nucl Med; 1994 Mar; 35(3):510-5. PubMed ID: 7906729 [TBL] [Abstract][Full Text] [Related]
13. Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Sugawara I; Kataoka I; Morishita Y; Hamada H; Tsuruo T; Itoyama S; Mori S Cancer Res; 1988 Apr; 48(7):1926-9. PubMed ID: 2894894 [TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical observation of multidrug resistance (MDR) p170 glycoprotein expression in human osteosarcoma cells. The clinical significance of MDR protein overexpression. Bodey B; Taylor CR; Siegel SE; Kaiser HE Anticancer Res; 1995; 15(6B):2461-8. PubMed ID: 8669809 [TBL] [Abstract][Full Text] [Related]
15. Epitope mapping of the monoclonal antibody MM12.10 to external MDR1 P-glycoprotein domain by synthetic peptide scanning and phage display technologies. Romagnoli G; Poloni F; Flego M; Moretti F; Di Modugno F; Chersi A; Falasca G; Signoretti C; Castagna M; Cianfriglia M Biol Chem; 1999 May; 380(5):553-9. PubMed ID: 10384961 [TBL] [Abstract][Full Text] [Related]
16. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells. Liu ZL; Hirano T; Tanaka S; Onda K; Oka K J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters. Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993 [TBL] [Abstract][Full Text] [Related]
18. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential. Alemán C; Annereau JP; Liang XJ; Cardarelli CO; Taylor B; Yin JJ; Aszalos A; Gottesman MM Cancer Res; 2003 Jun; 63(12):3084-91. PubMed ID: 12810633 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists. Yang JM; Goldenberg S; Gottesman MM; Hait WN Cancer Res; 1994 Feb; 54(3):730-7. PubMed ID: 7905786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]